Co-administration of AYUSH 64 as an adjunct to standard of care in mild and moderate COVID-19: A randomized, controlled, multicentric clinical trial.
Arvind ChopraGirish TilluKuldeep ChuadharyGovind ReddyAlok SrivastavaMuffazal LakdawalaDilip GodeHimanshu ReddySanjay TamboliManjit SalujaSanjeev SarmukaddamManohar GundetiAshwini Kumar RautB C S RaoBabita YadavNarayanam SrikanthBhushan PatwardhanPublished in: PloS one (2023)
CTRI/2020/06/025557.